Materials·Commodity Chemicals·$3.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.66 | N/A | +2.33% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.66 | N/A | +2.33% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, indicating a positive outlook despite not providing specific revenue guidance. They emphasized their commitment to long-term growth.
We are pleased with our EPS performance this quarter.
While we did not provide specific revenue figures, we remain focused on our long-term growth strategy.
Hawkins Inc's earnings report shows a positive surprise in EPS, which contributed to a 1.81% increase in stock price. The lack of revenue figures and guidance may leave some investors cautious, but the EPS beat suggests the company is managing its costs effectively. Overall, the market reacted favorably to the earnings surprise.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
VERTEX PHARMACEUTICA
Oct 25, 2010